Skip to main content
NCBI home page
Frontiers in Pharmacology logoLink to Frontiers in Pharmacology
. 2021 Apr 8;12:643242. doi: 10.3389/fphar.2021.643242

Phytochemical Screening and Antidiabetic, Antihyperlipidemic, and Antioxidant Effects of Leptopus Cordifolius Decne. In Diabetic Mice

Shahid Rahman 1, Gul Jan 1,*, Farzana Gul Jan 1,✉, Hafeez Ur Rahim 2
PMCID: PMC8060645  PMID: 33897432

Abstract

Plants are well known in traditional herbal medicines for their hypoglycemic and hypolipidemic activities and are often used due to their accessibility, affordability, and corollary effects. Leptopus cordifolius has been reported to control diabetes in folkloric medicine, but no known scientific research has been conducted to assess the plausibility of this assertion. Therefore, the current study is aimed to investigate the antidiabetic and hypolipidemic effects of Leptopus cordifolius leaves in alloxan-induced diabetic mice. The antidiabetic and antihyperlipidemic evaluation was conducted in Swiss albino mice at doses of 150–250°mg/kg for 15°days. The blood glucose, total cholesterol, triglyceride, LDL, HDL, creatinine, ALP, SGPT, and SGOT levels were estimated according to standard procedures. Phytochemicals of leaves were analyzed using GC-MS analysis. Enzymatic antioxidant activity of the plant was investigated spectrophotometrically by carrying out superoxide dismutase, peroxidase, and catalase assays. The membrane stabilization potential of L. cordifolius leaf extracts was carried out using an in vitro haemolytic assay. The results revealed a dose response effect with the methanolic extract of L. cordifolius which had significant antihyperglycemic effects at 150–250°mg/kg in alloxan treated mice, although less than the positive control (glibenclamide). Hyperlipidemic activity was significant at 250 mg/kg. The biochemical parameters, such as total cholesterol, triglyceride, LDL, HDL, creatinine, ALP, SGPT, and SGOT, were significantly improved (p < 0.01) by the methanolic extract of 250 mg/kg compared to the diabetic group. Treatment for 15 days showed significant elevation (p < 0.01) of antioxidant enzymes. GC-MS analysis provided tentative identifications of 52 compounds in the methanolic extract of L. cordifolius, of which 12 compounds have reported antidiabetic activity. In conclusion, methanolic extract of L. cordifolius of 150 and 250°mg/kg body weight showed significant antidiabetic and antihyperlipidemic activities in alloxan-induced diabetic mice and, with further work, has the potential to be used to manage blood glucose and cholesterol levels.

Keywords: antidiabetic, alloxan, lipid profile, antioxidant., leptopus cordifolius

graphic file with name fphar-12-643242-g002.jpg

Open in a new tab

GRAPHICAL ABSTRACT

Introduction

Diabetes mellitus is one of the most severe and incurable metabolic disorders, characterized by an increase in blood glucose level due to an absolute or relative lack of insulin and failure of insulin to act on its target tissue (Dey et al., 2015). Chronic hyperglycemia in diabetes is associated with long-term damage, dysfunction, and failure of various organs (Bajpay, 1993). Diabetes mellitus is known to cause hyperlipidemia through various metabolic derangements. Among several metabolic derangements, insulin deficiency has been known to stimulate lipolysis in the adipose tissue and give rise to hyperlipidemia (Ahmad et al., 2014). The number of people suffering from diabetes is increasing due to urbanization, demographic growth, aging, and growing incidences of obesity and lack of exercise (Badran and Laher, 2012). The existing drug therapies of sulfonylureas, biguanides, α-glucosidase inhibitors, and glinides have challenges in terms of cost, safety, and efficacy (Omonije et al., 2019). In particular, these hypoglycemic agents may cause adverse effects like renal toxicity, hypoglycemia, hepatotoxicity, and gastrointestinal disorders (Carpio and Fonseca, 2014).

Medicinal plants in this regard have become popular because of their perceived fewer side effects and many biological activities (Peiris et al., 2015). The antidiabetic medicinal plants may provide valuable sources for finding safer hypoglycemic agents Ethnobotanical statistics estimate that 1,200 rare plants worldwide may have antidiabetic potential (Arumugam et al., 2013)

Leptopopus cordifolius Decne (syn. Andrachne cordifolia) is a medicinal plant belonging to the family Phyllanthaceae, commonly found in the low hills of Northern hilly areas of Pakistan and the Himalayan region, including Azad Jammu and Kashmir. It is a small shrub, about 1 m tall, with ovate to elliptic leaves. It is distributed in Pakistan, Kashmir, India, and Nepal, on plains as well as on rocks, cliffs, wastelands, and on the bank of streams. The powder of the leaves of L. cordifolius is used for healing wounds and as a hypoglycemic agent (Ajaib, 2012; Munir and Qureshi, 2018). However, to the best of our knowledge, no scientific study documenting the antihyperglycemic and antihyperlipidemic behavior of L. cordifolius is available. Therfore, the current study was designed to investigate the antidiabetic ability of L. cordifolius in an alloxan-induced model of diabetic mice.

Materials and Methods

Collection and Processing of Plant

The L. cordifolius taxonomically identified leaves were collected from District Buner, northwest of Pakistan, after confirmation of its identification and authentication. The sample specimen with voucher number (AWKB-002) was deposited in the Herbarium of Botany Department Abdul Wali Khan University Mardan for future reference. The leaves of the plant were washed and air-dried for two weeks under shade. Using an electric grinder, they were ground to a uniform coarse powder and held in an airtight container at room temperature until it was used for extraction.

Preparation of Extract

The powdered leaves of L. cordifolius were extracted by direct mollescence method using 70% methanol for 72°h. The extracts were weighed and the percentage yield was calculated by using the formula (David et al., 2017).

% Yield = Weight of the Crude Extract/Weight of Dried powdered sample ×100.

Experimental Animals

The Swiss albino mice of 25––3°g weight and 3–4°weeks of age of either sex were utilized in the experiment. In compliance with OECD guidelines (Guideline, 2001), experimental animals were acclimatized to laboratory conditions for one week with free access during the experimental time to commercial pellet laboratory diets and water ad libitum (Council, 2010). The experimental animal’s procedures were used with the approval of an ethical committee of the Department of Pharmacy, Abdul Wali Khan University Mardan (0015/2019). Animals under ether anesthesia were killed and sacrificed at the end of the experiment.

Diabetes Induction in Experimental Animals

Diabetes was provoked in overnight fasted mice by intraperitoneal injection of a single dose of alloxan monohydrate (150 mg/kg) (Szkudelski, 2001). The induction of diabetes was confirmed in mice 3 days after injection of alloxan by measuring the level of blood glucose. The animals with a blood glucose level greater than 200 mg/ml were considered as diabetic (Tzeng et al., 2014) and were designated for the study. The treatment with methanolic extracts, glibenclamide, and solvent fractions was initiated 72 h after alloxan injection to the mice.

Acute Toxicity Study

An acute toxicity test was conducted in conjunction with the limit test recommended by Guideline 425 of the Organization for Economic Cooperation and Development (Guideline, 2001). The tests for acute toxicity were carried out using a fixed-dose protocol. Gross behavioral changes such as tremors, traction, salivation, loss of appetite, lacrimation, hair erection, diarrhea, mortality, and other symptoms of toxicity for 15°days were observed in the mice (Alema et al., 2020).

Experimental Design

The mice were divided into nine groups consisting of six mice in each group. Group 1 served as normal control (saline, non-diabetic), group 2 served as alloxan (150°mg/kg)-treated control (diabetic control), group 3 received glibenclamide (10°mg/kg), group 4 and 5 received L. cordifolius methanolic extracts at the dose of 150 and 250°mg/kg respectively, whereas group 6, 7, 8, and 9 received n-hexane, chloroform, ethyl acetate, and aqueous fractions at the dose of 250 mg/kg orally. The treatment procedures lasted for 15 successive days. The extracts and saline solution were administered via oral gavage.

Determination of Anti-diabetic Activity

The anti-diabetic ability of extracts and solvent fractions were assessed by an in vivo oral glucose tolerance test (OGTT) using albino mice at a dose of 150 and 250°mg/kg body weight. The dose of 150 and 250°mg/kg body weight were selected based on the effectiveness of their traditional claim (Shukla et al., 2011).

Blood Glucose Determination

The blood glucose level of each mouse was determined by fractional tail amputation technique, taking blood from the tail vein by a one-touch electronic glucometer using glucose test strips (Akpan et al., 2012). The tails were then rubbed with ethanol to prevent infection.

Body Weight Analysis

The body weight of the experimental animals was recorded before commencing the treatment (day 0) and throughout the experiment (day 7 and 15), and fluctuations in weight were recorded.

Collection and Preparation of Blood Sample

Blood samples were collected from 24°h-fasted mice by cardiac puncture and retro-orbital plexus puncture method and were kept in sterile vials for 30°min for clotting. Serum samples were collected from clotted blood using a centrifuge operated at 3,000°rpm for 10 min (Chou et al., 2008; Parasuraman et al., 2015).

Collection of Organs

The mice were anesthetized under mild ether and dissected. The tissue sample was taken for assessment of biochemical parameters (Li et al., 2008).

Biochemical Analysis

The serum samples were then used for estimation of biochemical parameters such as alkaline phosphatase (ALP) (Sasaki, 1966), creatinine (Bowers, 1980), total cholesterol (TC) and triglycerides (TG) (Roeschlau et al., 1974), LDL (Friedewald et al., 1972), and HDL (Iwata et al., 1990).

The Serum Glutamate Pyruvate transaminase (SGPT) and Serum Glutamic Oxaloacetic transaminase (SGOT) activities were determined according to the method of Reitman and Frankel (Reitman and Frankel, 1957). These biochemical assays were measured by using commercial diagnostic kits.

Histopathological Analysis

The liver, kidney, and pancreas of animals were expunged at the termination of the experiment and engrossed in 10% buffered formal-saline for histopathological investigations using Hematoxylin and Eosin (H&E) stains. The morphological changes in hepatic and pancreatic cells were examined under a microscope on albumenized glass slides, using 20× and 40× magnifications (Bancroft and Gamble, 2008).

Antioxidant Enzyme Assay

The spectrophotometric measurement of antioxidant enzymatic activity of Superoxide dismutase SOD (Shah et al., 2013), peroxidase POD (Khan et al., 2015), and Catalase CAT (Khan et al., 2012) was carried out at 560, 420, and 230°nm respectively.

Membrane Stabilization Assay

The membrane-stabilizing activity of the extracts was determined on human erythrocytes by collecting fresh blood samples from 10 volunteers and the absorbance was measured at 560°nm (Shinde et al., 1999; Omale and Okafor, 2008).

GC-MS Profiling

A 20 mg sample of leaf powder was dissolved in 1°ml of methanol, vortexed for 5°min, sonicated for 10°min, and then centrifuged for 5°min at 12,000x°g. The supernatant was transferred into a fresh vial and was subjected (without any dilution) to GC-MS analysis.

GC-MS analysis of the active methanolic extract of L. cordifolius was carried out by using the GC-MS instrument (Model GCMS-QP2010 Ultra, Shimadzu Co., Japan) equipped with a capillary column DB-1 (0.25°μm film × 0.25°mm i. d. ×30° m length). The instrument was operated in electron impact mode at ionization voltage (70°eV), injector temperature (230°C), and detector temperature (280°C). The carrier gas used was helium (99.9% purity) at a flow rate of 1 ml/min and about 1 μL of the sample was injected. The tentative identification of compounds from the spectral data was based on the available mass spectral records (NIST and WILEY libraries) (Swamy et al., 2015).

Statistical Analysis

All the values were expressed as mean ± Standard Error of the Mean (SEM). The results were analyzed for statistical significance using one-way ANOVA followed by Dunnett’s test with the aid of IBM Statistical Package for Social Scientist (SPSS-20). The level of significance was set at p < 0.05.

Results

Extraction Yield

The extraction yield of methanolic extract and different partitions of L. cordifolius showed that the extraction with methanol had the highest yield compared to the solvent extraction (Table 1).

TABLE 1.

Extraction yield of L. cordifolius.

S.No Plant extracts Weight (g) Percent yield (%)
1 Methanolic extract 430 91.48
2 n-Hexane 55 11.70
3 Chloroform 190 40.42
4 Ethyl acetate 58 12.34
5 Aqua 127 27.02
Open in a new tab

Acute Toxicity Study

The extract was found benign up to a dose of 2000 mg/kg body weight from the safety data obtained. The behavior of the animals during the study was closely monitored and no lethality, behavioral changes, or mortality was noticed, which is regarded as a therapeutic benefit.

Blood Glucose Level

The administration of the methanolic extract of L. cordifolius at 150 and 250°mg/kg significantly reduced (p < 0.01) the blood glucose level in diabetic mice at the end of the experiment in a dose dependent fashion, but less than glibenclamide-treated mice. Other extracts were not effective. (Table 2).

TABLE 2.

Effects of L. cordifolius extracts on blood glucose level of alloxan-induced diabetic mice.

S.No Treatments Dose (mg/kg) Blood glucose level (mg/dl)
Day 0 Day 4 Day 7 Day 10 Day 15
1 Normal Saline 0.3 ml 100.4 ± 2.7 98.4 ± 3.2 97.4 ± 1.9 96.4 ± 4.2 94 ± 3.6
2 Diabetic Control 0.3 ml 424.6 ± 2.7 438.8 ± 3.3 466.6 ± 2.7 474.8 ± 2.3 490 ± 2.7
3 Glibenclamide 10 431.4 ± 3.3 402.8* ± 2.8 360.6* ± 3.04 272.2** ± 4.9 206.6** ± 5.4
4 Methanolic Extract (1) 150 435.8 ± 4.4 412.6* ± 2.7 387.4* ± 3.6 346.6* ± 4.9 304.2* ± 2.8
5 Methanolic Extract (2) 250 431.2 ± 3.9 408* ± 3.16 360.8* ± 3.1 320.8* ± 2.8 270.4** ± 4.5
6 n-Hexane 250 459.2 ± 3.4 458.2 ± 4.2 449.4 ± 3.8 454.6 ± 4.5 466.8 ± 2.16
7 Chloroform 250 455.6 ± 3.6 453.8 ± 3.4 440.4 ± 3.04 429.6 ± 3.36 414.2 ± 4.3
8 Ethyl acetate 250 419.8 ± 3.03 417.4 ± 3.04 421.2 ± 4.08 425.6 ± 2.4 440 ± 4.4
9 Aqua 250 414 ± 2.9 412.6 ± 3.6 412 ± 2.8 433.4 ± 4.03 456.2 ± 1.9
Open in a new tab

Values are expressed as mean ± SEM n = 6 in each group. Data analyzed by ONE WAY ANOVA followed by 187 Dunnett’s multiple comparisons test. * P < 0.05; **P < 0.01; compared with diabetic control.

Changes in Body Weight and Fasting Blood Glucose Level

The methanolic extracts at the dose of 150 and 250 significantly improved the body weight (p < 0.05; p < 0.01) in alloxanised diabetic mice and produced maximum fall (p < 0.01) in the FBG levels of diabetic mice after 15 days of treatment (Table 3). Other extracts were not effective.

TABLE 3.

Effects of L. cordifolius extracts on body weight of mice.

S.No Treatments Dose (mg/kg) Body weight (g)
Day 0 Day 4 Day 7 Day 10 Days 15
1 Normal Saline 0.3 ml 22.2 ± 0.28 23.6 ± 0.20 24.6 ± 0.25 26.1 ± 0.47 26.8 ± 0.45
2 Diabetic Control 0.3 ml 29.2 ± 0.49 28.6 ± 0.38 26.3 ± 0.49 25.4 ± 0.38 24.5 ± 0.33
3 Glibenclamide 10 30.3 ± 0.28 31.9 ± 0.38 32.8* ± 0.43 33.5* ± 0.31 34.9** ± 0.22
4 Methanolic Extract(1) 150 30.8 ± 0.27 31.7 ± 0.54 32.4* ± 0.36 32.6 ± 0.53 33.1* ± 0.36
5 Methanolic Extract(2) 250 29.3 ± 0.33 30.6 ± 0.93 32.4* ± 0.36 33.1* ± 0.41 34.6** ± 0.27
6 n-Hexane 250 28.8 ± 0.27 28.2 ± 0.28 27.5 ± 0.24 27 ± 0.27 26.2 ± 0.31
7 Chloroform 250 27.5 ± 0.28 27.3 ± 0.36 28.2 ± 0.16 28.4 ± 0.22 29.2 ± 0.20
8 Ethyl acetate 250 29.5 ± 0.29 28.5 ± 0.31 27.6 ± 0.23 26.6 ± 0.22 25.7 ± 0.27
9 Aqua 250 29.2 ± 0.20 28.6 ± 0.19 27.8 ± 0.20 26.7 ± 0.20 25.5 ± 0.27
Open in a new tab

Values are expressed as mean ± SEM n = 6 in each group. Data analyzed by ONE WAY ANOVA followed by Dunnett’s multiple comparisons test. * P < 0.05; **P < 0.01; compared with diabetic control.

Lipid Profile

The lipid profile in diabetic mice was severely disturbed in diabetic mice by alloxan administration when compared with the control group. The methanolic extract at the dose of 150 and 250°mg/kg of L. cordifolius significantly reduced the levels of lipid parameters to near normal (Table 4). Other extracts were not effective.

TABLE 4.

Effects of L. cordifolius extracts on lipid profile parameters.

S.No Treatments Dose (mg/kg) TC (mg/dl) TG (mg/dl) LDL (mg/dl) HDL (mg/dl)
1 Normal Saline 0.3 ml 181.3 ± 1.45 163.3 ± 4.7 173 ± 1.1 35 ± 0.5
2 Diabetic Control 0.3 ml 183.4 ± 1.45 167.6 ± 1.76 161.9 ± 12.1 36.6 ± 0.4
3 Glibenclamide 10 136.4** ± 0.9 145.8** ± 0.7 125.4** ± 0.2 43.4** ± 0.5
4 Methanolic Extract(1) 150 165.1 ± 3.52 154.8 ± 1.9 142.3 ± 0.3 40.9 ± 1.6
5 Methanolic Extract(2) 250 154.7** ± 3.76 148** ± 1.7 128.6** ± 0.7 41.2** ± 1.2
6 n-Hexane 250 178.4 ± 1.90 164.3 ± 0.6 147.4 ± 0.4 35.6 ± 0.7
7 Chloroform 250 171.5 ± 5.7 165.5 ± 3.7 143.7 ± 0.4 37.3 ± 0.6
8 Ethyl acetate 250 178.4 ± 1.81 165.3 ± 0.7 147.3 ± 0.6 35.8 ± 0.9
9 Aqua 250 178.8 ± 1.11 166.3 ± 1.03 148.4 ± 0.7 35.2 ± 0.4
Open in a new tab

Values are expressed as mean ± SEM n = 6 in each group. Data analyzed by ONE WAY ANOVA followed by Dunnett’s multiple comparisons test. * P < 0.05; **P < 0.01; compared with diabetic control.

Serum Profile

A significant elevation in SGPT, SGOT, ALP, and creatinine was observed in alloxan-induced diabetic mice when compared to normal mice. Oral administration of L. cordifolius leaves, methanolic extract 150 and 250°mg/kg, and glibenclamide treatment significantly improved the above parameters (Table 5).

TABLE 5.

Effects of extracts of L. cordifolius on serum biochemical parameters.

S.No Treatments Dose (mg/kg) SGPT (U/I) SGOT (U/I) ALP (U/I) Creatinine (mg/dl)
1 Normal Saline 0.03 ml 19.3 ± 2.08 23.4 ± 0.65 173.6 ± 6.77 1.05 ± 0.31
2 Diabetic Control 0.03 ml 48.4 ± 1.45 43.6 ± 1.45 331.3 ± 1.76 2.3 ± 0.08
3 Glibenclamide 0.03 ml 32.4** ± 0.36 25.2** ± 0.60 169.8** ± 1.44 0.98** ± 0.05
4 Methanolic Extract (1) 150 29.3 ± 2.86 30.5 ± 0.57 280 ± 1.41 1.87 ± 0.03
5 Methanolic Extract (2) 250 27.8** ± 2.60 26.4** ± 2.15 231.1** ± 2.25 1.26** ± 0.22
6 n-Hexane 250 37.3 ± 1.44 32.2 ± 0.17 280.9 ± 11.5 1.88 ± 0.02
7 Chloroform 250 33.5 ± 0.92 29.4 ± 1.15 270 ± 29.6 1.84 ± 0.04
8 Ethyl acetate 250 38.2 ± 1.43 34.2 ± 0.78 286.6 ± 15.5 1.90 ± 0.02
9 Aqua 250 35.9 ± 1.18 33.1 ± 0.31 296.1 ± 8.93 1.93 ± 0.02
Open in a new tab

Values are expressed as mean ± SEM; n = 6 in each group. ∗∗P < 0.01 as compared with diabetic control at the same time (one-way ANOVA followed by Dunnett’s multiple comparison test). TC, total cholesterol; TG, triglycerides; LDL, low density lipids and HDL, high density lipids.

Antioxidant Enzymes

Diabetes mellitus significantly reduced antioxidant enzymes, like catalases (CAT), peroxidases (POD), and superoxide dismutase (SOD) levels, and elevated the action of reactive oxygen species. The methanolic extract at the dose of 150 and 250°mg/kg significantly increased the activities of antioxidant enzymes. However, other extracts treated group showed no significant difference in comparison to the glibenclamide-treated group (Table 6).

TABLE 6.

Determination of antioxidant enzymes activity.

S. No Treatments Dose (mg/kg) SOD (U/mg) POD (U/mg) Catalase (U/mg)
1 Normal Saline 0.03 ml 4.87 ± 0.24 6.27 ± 0.23 9.38 ± 0.11
2 Diabetic Control 0.03 ml 3.72 ± 0.04 5.97 ± 0.02 8.63 ± 0.03
3 Glibenclamide 0.03 ml 2.02** ± 0.03 4.80** ± 0.03 4.57** ± 0.40
4 Methanolic Extract (1) 150 2.98* ± 0.03 3.90* ± 0.22 5.04* ± 0.26
5 Methanolic Extract (2) 250 2.66 ** ± 0.10 4.62** ± 0.09 4.94** ± 0.60
6 n-Hexane 250 3.41 ± 0.12 2.86 ± 0.03 5.62 ± 0.32
7 Chloroform 250 3.71 ± 0.21 3.32* ± 0.27 5.41 ± 0.06
8 Ethyl acetate 250 3.12 ± 0.18 2.66 ± 0.14 5.91 ± 0.26
9 Aqua 250 2.95 ± 0.23 2.36 ± 0.17 5.85 ± 0.03
Open in a new tab

Values are expressed as mean ± SEM; n = 6 in each group. ∗∗P < 0.01 as compared with diabetic control at the same time (one-way ANOVA followed by Dunnett’s multiple comparison test). SGPT, Serum Glutamate Pyruvate Transaminase; SGOT, Serum Glutamic Oxaloacetic Transaminase; ALP, alkaline phosphatase.

Membrane Stabilizing Activity

In the hypotonic-solution-induced condition, methanolic extract showed the highest protection of erythrocyte membrane (76%), which was comparable to haemolysis inhibited by standard acetyl salicylic acid (Table 7).

TABLE 7.

Thrombolytic activity of A. cordifolia extract/fractions.

S.No Extract/Fractions Concentration (mg/ml) Thrombolytic activity % Inhibition
1 Methanolic 1 0.1678 ± 0.06 76
2 n-Hexane 1 0.6016 ± 0.03 14.6
3 Chloroform 1 0.4411 ± 0.05 37.4
4 Ethyl acetate 1 0.5016 ± 0.04 28.8
5 Aqueous 1 0.5737 ± 0.19 18.6
6 Acetyl salicylic acid (Control) 0.10 0.705 ± 0.06 86
Open in a new tab

Values are expressed as mean ± SEM. Data analyzed by ONE WAY ANOVA followed by Dunnett’s multiple comparisons test. * P < 0.05; **P < 0.01, compared with diabetic control. Data are expressed as mean ± SD (n = 3).

GC-MS Analysis

The results of GC-MS analysis revealed the tentative identity of 52 compounds present in methanolic extract L. cordifolius. The active principles with their retention time, probability, molecular weight, and concentration (peak area %) are presented in Table 8 and Figure 1.

TABLE 8.

Chemical constituents from GC-MS analysis of methanolic extract of L. cordifolius.

S.No Compound Name Area % RT Probability Molecular formula MW
1 Amyl Nitrite 13.62 1.24 12.42 C5H11NO2 117
2 Pentane, 3-methyl 13.62 1.24 11.46 C5H11NO2 86
3 Butyl glycolate 13.62 1.24 11.46 C6H12O3 132
4 Furfural 0.38 2.14 52.91 C5H4O2 96
5 3-Furaldehyde 0.38 2.14 37.35 C5H4O2 96
6 2-Furanmethanol 0.55 2.47 54.29 C5H6O2 98
7 [1,3,4]Thiadiazol,2-amino-5-(2-piperidin-1-ylethyl)- 0.69 3.30 8.96 C9H16N4S 212
8 1-Piperidineethanol 0.69 3.30 6.14 C7H15NO 129
9 4H-Pyran-4-one, 2, 3-dihydro-3,5-dihydroxy-6-methyl- 0.52 3.87 17.90 C6H8O4 144
10 2-Propyl-tetrahydropyran-3-ol 0.52 3.87 10.42 C8H16O2 144
11 Deoxyspergualin 0.03 4.30 21.53 C17H37N7O3 387
12 1,3,9-Trioxaspiro[5.5]undecane 0.33 4.93 18.62 C8H14O3 158
13 2,5-Dimethyl-4-hydroxy-3(2H)-furanone 0.92 5.58 31.53 C6H8O3 128
14 3-Propylnorleucine 4.32 5.58 4.32 C9H19NO2 173
15 a-D-Glucopyranoside 0.08 6.30 33.47 C18H32O16 504
16 Desulphosinigrin 0.08 6.30 9.84 C10H17NO6S 279
17 4H-Pyran-4-one, 2,3-dihydro-3,5-dihydroxy-6-methyl 1.59 7.13 92.67 C6H8O4 144
18 2-Hydroxy-4,6-dimethylbenzaldehyde 1.75 8.07 9.59 C9H10O2 150
19 2-Furancarboxaldehyde, 5-(hydroxymethyl)- 3.49 8.74 94.95 C6H6O3 126
20 2-Methoxy-4-vinylphenol 0.92 9.27 11.48 C9H10O2 150
21 α-D-Glucopyranosyl-(1->3)-β-D-fructofuranosyl β-D-glucopyranoside 0.11 9.82 30.85 C18H32O16 504
22 d-Mannose 0.11 9.82 14.05 C6H12O6 180
23 Ethaneperoxoic acid 1.89 10.39 10.90 C12H13NO3 219
24 Furan, 2-(2-furanylmethyl)-5-methyl- 0.57 10.82 29.36 C10H10O2 162
25 Decanal 5.80 11.45 5.31 C10H20O 156
26 1,12-Dodecanediol 5.80 11.45 4.28 C12H26O2 202
27 1,10-Decanediol 29.35 12.02 13.90 C10H22O2 174
28 Z-10-Pentadecen-1-ol 1.74 12.45 8.65 C15H30O 226
29 2H-Pyran-2-one, tetrahydro-4-hydroxy-6-pentyl 5.53 13.67 14.68 C10H18O3 186
30 9-Hexadecenoic acid 1.16 14.59 39.48 C16H30O2 254
31 Tetraacetyl-D-xylonic nitrile 0.83 14.83 7.66 C14H17NO9 343
32 Oleic Acid 0.39 15.22 11.04 C18H34O2 282
33 Tetradecanoic acid 1.04 16.54 73.29 C14H28O2 228
34 l-Gala-l-ido-octonic lactone 1.45 17.34 20.87 C8H14O8 238
35 Cholestan-3-ol, 2-methylene- 0.09 17.78 44.09 C28H48O 400
36 Hexadecanoic acid, methyl ester 1.02 18.29 59.66 C17H34O2 270
37 n-Hexadecanoic acid 4.57 18.74 75.24 C16H32O2 256
38 7-Methyl-Z-tetradecen-1-ol acetate 0.02 19.41 56.16 C17H32O2 268
39 9,12-Octadecadienoyl chloride 0.59 19.66 15.80 C18H31ClO 298
40 l-Gala-l-ido-octonic lactone 1.45 17.34 20.87 C18H32O16 504
41 10-Methyl-8-tetradecen-1-ol acetate 1.59 20.84 26.48 C17H32O2 268
42 Dasycarpidan-1-methanol, acetate 1.20 21.25 35.93 C20H26N2O2 326
43 9,12,15-Octadecatrienoic acid, 2,3-dihydroxypropyl ester 1.29 23.10 47.72 C21H36O4 352
44 8-(2-Aminoethylthio)guanosine-3′,5′-cyclic monophosphate 0.83 23.88 97.72 C12H16N6O7PS 419
45 Palmitic acid, 9-hexadecenyl ester, (Z)- 0.32 24.28 11.27 C32H62O2 478
46 Vitamin E 1.20 25.08 55.93 C29H50O2 430
47 β-sitosterol 3.11 25.93 42.59 C29H50O 414
48 Stigmasterol, 22,23-dihydro- 3.11 25.93 19.97 C29H50O 414
49 Olean-13(18)-ene 0.55 26.50 41.48 C30H50 410
50 Carotene, 1,1′,2,2′-tetrahydro-1,1′-dimethoxy 0.01 27.19 61.58 C42H64O2 600
51 Ergost-8(14)-en-3-ol 0.01 27.19 11.54 C28H48O 400
52 Betulin 0.15 27.91 11.94 C30H50O2 442
Open in a new tab

RT, Retention time; MW, Molecular weight.

FIGURE 1.

FIGURE 1

Open in a new tab

GC-MS chromatogram of L. cordifolius extract.

Discussion

The current research study investigated the antidiabetic and antihyperlipidemic effects of the methanolic extracts and solvent fractions of L. cordifolius in alloxan-induced diabetic mice. Alloxan is a cytotoxic glycoside and acts as a diabetogenic by the annihilation of the islets of Langerhans and causes an enormous decline in insulin discharge, thus prompting hyperglycemia (Grover et al., 2000). Glibenclamide is used as a standard antidiabetic drug in alloxan-induced mild diabetes to compare the antidiabetic effects of a variety of bioactive compounds (Ramkumar et al., 2011). The extracts were found to be safe up to the dose of 2000 mg/kg in normal healthy mice from the safety data obtained (Yehya et al., 2019).

Alloxan induces diabetes through ROS that leads to rapid destruction of pancreatic beta cells, causing hyperglycemia (Stanely et al., 2000). Hyperglycemia in turn increases the generation of free radicals by glucose auto-oxidation (Bajaj and Khan, 2012). In the current research study, oral administration of L. cordifolius methanolic extract of 150 and 250 mg/kg body weight to diabetic mice for 15°days significantly reduced the fasting blood glucose and glycerides were reduced only at 250°mg/k, compared with diabetic control mice. In support of our study, the L. cordifolius methanolic extract (250°mg/kg body weight) cause their anti-hyperglycemic activity by augmenting the production of insulin or regenerating pancreatic cells (Patel et al., 2012). Although the effective doses of 150 and 250°mg/kg reported here are comparable with other antidiabetic plants (Ghazanfar et al., 2014; Alema et al., 2020), they are at the upper end of the dose range and further research needs to be done to concentrate the active principles and thereby reduce the effective dose. Unfortunately, the results with different solvents did not achieve this result as they were less effective than methanol. The observed decline in body weight of diabetic mice could be attributed to the surging body mass index and the progression of skeletal size and epididymis fats (Wu and Huan, 2008). However, treatments with orally administered methanolic, and chloroform extracts of 250°mg/kg significantly improved the body weight compared with diabetic control, which signifies its protective effect in controlling muscle wasting i.e. reversal of gluconeogenesis (Mestry et al., 2017). In diabetes mellitus, hyperlipidemia occurs as a result of the excess mobilization of fats from the adipose tissue due to the underutilization of glucose (Akpan et al., 2012). Hyperglycemia is accompanied by a rise in TC, TG, and LDL, and a fall in HDL levels (Gao et al., 2009). The methanolic extract L. cordifolius and gibenclamide might act on reserved fats and inhibit the release of free fatty acids, decreasing the total cholesterol and triglyceride levels, and increasing the HDL level.

It is acknowledged that diabetes is linked to irreversible hepatic damage leading to the proliferation of different enzymes including SGOT, SGPT, ALP, and creatinine in the blood (Pari and Latha, 2002; Preethi and Kuttan, 2009). L. cordifolius methanolic extract significantly reduced the serum creatinine, thus treating and preventing the progression of renal damage in diabetic mice. Reports have shown that the reversal of such changes in the above parameters is allied with the presence of bioactive constituents in the extract (Lal et al., 2009; Sharma et al., 2019). In diabetes mellitus, high glucose can inactivate antioxidant enzymes SOD, POD, and, CAT by glycating these proteins, thus producing induced oxidative stress, which in turn causes lipid peroxidation. The L. cordifolius methanolic extract increased the activities of SOD, POD, and CAT, thus maintaining the antioxidant status in the erythrocytes of diabetic mice. Several studies revealed that injury to membranes of RBCs due to hyperglycemia makes cells more susceptible to secondary damage through lipid peroxidation, haemolysis, and oxidation of haemoglobin (Halliwell, 1999). The inhibition of the erythrocyte lysis property of L. cordifolius could be the possible mechanism for its anti-diabetic activity. It may also be due to the presence of plant biochemical compounds in the extract which exert a profound stabilizing effect on lysosomal membranes and their cation-binding ability (Oyedapo et al., 2004).

Various secondary metabolites and phytochemicals isolated from diverse plant species have been found to have potent anti-hyperglycemic and glucose suppressive effects (Sharma et al., 2010). The secondary metabolites which were tentatively identified in L. cordifolius crude methanolic extract may be accountable for its observed glucose suppressive and anti-hyperglycemic activity, due to its ability to stimulate glycogenesis in the liver, release insulin from pancreatic ß-cells, or inhibit glucose absorption in the gut (Sezik et al., 2005).

Several studies revealed that injury to membranes of RBCs makes cells more susceptible to secondary damage through lipid peroxidation, haemolysis, and oxidation of haemoglobin (Halliwell and Whiteman, 2004). The inhibition of the erythrocyte lysis property of L. cordifolius could also be the possible mechanism for its anti-diabetic activity (Chaitanya et al., 2011). GC-MS analysis of methanolic extract of L. cordifolius tentatively identified the presence of various bioactive compounds with different retention times. The tentatively identified compounds are known to possess several biological and pharmacological activities (Grover et al., 2002; Kumar et al., 2010; Hema et al., 2011). Several studies have shown that ß-Sitosterol, stigmasterol, betulin, ergost-8(14)-en-3-ol, n-hexadecanoic acid, and palmitic acid have been found to have hypoglycemic effects by reducing the absorptions of cholesterol from the gut as shown in the Table 9 (Ikeda et al., 1988; Rajasekaran et al., 2004).

TABLE 9.

Antidiabetic compounds identified from GC-MS.

S.NO Compounds Compounds nature References
1 Betulin Triterpene Birgani et al. (2018)
2 Ergost-8(14)-en-3-ol Steroid Luo et al. (2010)
3 Vitamin E Vitamin Bharti et al. (2012)
4 Stigmasterol Steroid Panda et al. (2009), Gabay et al. (2010), Tyagi and Agarwal (2017)
5 a-D-Glucopyranoside, O-a-D-glucopyranosyl-(1.fwdarw.3)-a-D –fructofuranosyl Steroid Kadhim et al. (2017), Al-Gara et al. (2019)
6 l-Gala-l-ido-octonic lactone Steroid Kadhim et al. (2017)
7 Dasycarpidan-1-methanol, acetate Ester Al-Gara et al. (2019)
8 β-sitosterol Steroid Gupta et al. (2011)
9 d-Mannose Sugar van de Venter et al. (2008)
10 n-hexadecenoic acid Ester Parker et al. (2003)
11 13-Octadecenoic acid Ester Su et al. (2013)
12 2-Methoxy-4-vinylphenol Phenolic Vadivel and Gopalakrishnan (2011)
Open in a new tab

Conclusion

The current research study demonstrated the first pharmacological insight into the antioxidant, antidiabetic, and antihyperlipidemic potential of the L. cordifolius. Based on the results exhibited by this study, it is concluded that L. cordifolius methanolic extract had significant anti-hyperglycemic activity in alloxan-induced diabetic mice compared with that of glibenclamide, as evident from the restoration of blood glucose levels, thus validating its traditional utilization. Future research needs to focus on bioassay guided isolation and confirmed identification of the active principles using standard or spectral workup. This could inform better extraction and formulation procedures to lower the dose required, as well as lead to a validated phytochemical analysis of a standardized product. Further study of the mode of action of active principles is warranted.

Acknowledgments

The authors are indebted to the staff and colleagues of the Department of Botany, Abdul Wali Khan University Mardan, for providing assistance.

Data Availability Statement

The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author.

Ethics Statement

The animal study was reviewed and approved by Veterinary Research Institute, Peshawar, Pakistan.

Author Contributions

SR and GJ designed, performed the experiment, and wrote the original manuscript. Statistical analysis, results, and discussion were accomplished by SR and FJ. HR assisted during data collection, visualization, characterizations, editing, and reviewing of the manuscript. All the authors read and approved the final manuscript.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  1. Ahmad W., Khan I., Khan M. A., Ahmad M., Subhan F., Karim N. (2014). Evaluation of antidiabetic and antihyperlipidemic activity of Artemisia indica linn (aeriel parts) in Streptozotocin induced diabetic rats. J. Ethnopharmacol. 151, 618–623. 10.1016/j.jep.2013.11.012 [DOI] [PubMed] [Google Scholar]
  2. Ajaib M. (2012). Exploration of floral diversity of District kotli (Azad Jammu & Kashmir) and evaluation of ethnopharmacological effects of some medicinal plants of the area. Pakistan: GC University Lahore. [Google Scholar]
  3. Akpan E. J., Okokon J. E., Offong E. (2012). Antidiabetic and hypolipidemic activities of ethanolic leaf extract and fractions of Melanthera scandens. Asian Pac. J. Trop. Biomed. 2, 523–527. 10.1016/S2221-1691(12)60089-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Al-Gara N. I., Abu-Serag N. A., Shaheed K. A. A., Al Bahadly Z. K. (2019). “Analysis of bioactive phytochemical compound of (Cyperus alternifolius L.) by using gas chromatography–mass spectrometry,” in IOP conference series: Mater. Sci. Eng. April 15, 2019, Iraq (United Kingdom: IOP Publishing; ), Vol. 571, 012047. [Google Scholar]
  5. Alema N. M., Periasamy G., Sibhat G. G., Tekulu G. H., Hiben M. G. (2020). Antidiabetic activity of extracts of Terminalia brownii fresen. Stem bark in mice. J. Exp. Pharmacol. 12, 61. 10.2147/JEP.S240266 [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Arumugam G., Manjula P., Paari N. (2013). A review: anti diabetic medicinal plants used for diabetes mellitus. J. Acute Dis. 2, 196–200. 10.1016/s2221-6189(13)60126-2 [DOI] [Google Scholar]
  7. Badran M., Laher I. (2012). Type II diabetes mellitus in Arabic-speaking countries. Int. J. Endocrinol. 2012, 902873. 10.1155/2012/902873 [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bajaj S., Khan A. (2012). Antioxidants and diabetes. Indian J. Endocrinol. Metab. 16, S267–S271. 10.4103/2230-8210.104057 [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Bajpay A. (1993). Ecological Studies of Boerhaavia verticillata poir with special reference to phytochemical and therapeutic importance. PhD thesis. Varanasi, India: Banaras Hindu University. [Google Scholar]
  10. Bancroft J. D., Gamble M. (2008). “Theory and practice of histological techniques,” in Journal of Neuropathology and Experimental Neurology. Editors Livingstone C., Philadelphia E. (California: Elsevier health sciences; ), Vol. 67, 633. [Google Scholar]
  11. Bharti S. K., Krishnan S., Kumar A., Rajak K. K., Murari K. (2012). Antihyperglycemic activity with DPP-IV inhibition of alkaloids from seed extract of Castanospermum australe: Investigation by experimental validation and molecular docking. Phytomed. 20, 24–31. 10.1016/j.phymed.2012.09.009 [DOI] [PubMed] [Google Scholar]
  12. Birgani G. A., Ahangarpour A., Khorsandi L., Moghaddam H. F. (2018). Anti-diabetic effect of betulinic acid on streptozotocin-nicotinamide induced diabetic male mouse model. Braz. J. Pharm. Sci. 54. 10.1590/s2175-97902018000217171 [DOI] [Google Scholar]
  13. Bowers L. D. (1980). Kinetic serum creatinine assays I. The role of various factors in determining specificity. Clin. Chem. 26, 551–554. 10.1093/clinchem/26.5.0551 [DOI] [PubMed] [Google Scholar]
  14. Carpio G. R. A., Fonseca V. A. (2014). Update on safety issues related to antihyperglycemic therapy. Diabetes Spectr. 27, 92–100. 10.2337/diaspect.27.2.92 [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Chaitanya R., Sandhya S., David B., Vinod K., Murali S. (2011). HRBC membrane stabilizing property of roor, stem and leaf of glochidion velutinum. Int. J. Res. Pharmaceut. Biomed. Sci. 2, 256–259. [Google Scholar]
  16. Chou Y. C., Tsai Y. C., Chen C. M., Chen S. M., Lee J. A. (2008). Determination of lipoprotein lipase activity in post heparin plasma of streptozotocin‐induced diabetic rats by high‐performance liquid chromatography with fluorescence detection. Biomed. Chromatogr. 22, 502–510. 10.1002/bmc.960 [DOI] [PubMed] [Google Scholar]
  17. Council N. R. (2010). Guide for the care and use of laboratory animals. Washington, DC: National Academies Press. [Google Scholar]
  18. David J., Afolabi E., Olotu P., Ojerinde S., Agwom F., Ajima U. (2017). Phytochemical analysis, antidiabetic and toxicity studies of the methanolic leaf extract of Detarium microcarpum guill and perr in wistar albino rats. Jaipur: Chandra Shekhar Sharma. [Google Scholar]
  19. Dey P., Saha M. R., Chowdhuri S. R., Sen A., Sarkar M. P., Haldar B., et al. (2015). Assessment of anti-diabetic activity of an ethnopharmacological plant Nerium oleander through alloxan induced diabetes in mice. J. Ethnopharmacol. 161, 128–137. 10.1016/j.jep.2014.12.012 [DOI] [PubMed] [Google Scholar]
  20. Friedewald W. T, Levy R. I., Fredrickson D. S. (1972). Estimation of the concentration of low density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifuge. Clin. Chem. 18, 499–502. 10.1093/clinchem/18.6.499 [DOI] [PubMed] [Google Scholar]
  21. Gabay O., Sanchez C., Salvat C., Chevy F., Breton M. (2010). Stigmasterol: a phytosterol with potential anti-osteoarthritic properties. Osteoarthr. Cartil. 18, 106–116. 10.1016/j.joca.2009.08.019 [DOI] [PubMed] [Google Scholar]
  22. Gao D., Li Q., Li Y., Liu Z., Fan Y., Liu Z., et al. (2009). Antidiabetic and antioxidant effects of oleanolic acid from Ligustrum lucidum Ait in alloxan‐induced diabetic rats. Phytother. Res. 23, 1257–1262. 10.1002/ptr.2603 [DOI] [PubMed] [Google Scholar]
  23. Ghazanfar K., Ganai B. A., Akbar S., Mubashir K., Dar S. A., Dar M. Y, et al. (2014). Antidiabetic activity of Artemisia amygdalina Decne in streptozotocin induced diabetic rats. Biomed. Res. Int. 2014, 185676. 10.1155/2014/185676 [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Grover J., Vats V., Rathi S. (2000). Anti-hyperglycemic effect of Eugenia jambolana and Tinospora cordifolia in experimental diabetes and their effects on key metabolic enzymes involved in carbohydrate metabolism. J. Ethnopharmacol. 73, 461–470. 10.1016/s0378-8741(00)00319-6 [DOI] [PubMed] [Google Scholar]
  25. Grover J., Yadav S., Vats V. (2002). Medicinal plants of India with anti-diabetic potential. J. Ethnopharmacol. 81, 81–100. 10.1016/s0378-8741(02)00059-4 [DOI] [PubMed] [Google Scholar]
  26. Guideline O. (2001). “Acute oral toxicity up and-down procedure,” in OECD guidelines for the testing of chemicals (Paris, OECD: Organization for Economic Cooperation and Development; ), Vol. 425, 27. [Google Scholar]
  27. Gupta R., Sharma A. K., Dobhal M., Sharma M., Gupta R. (2011). Antidiabetic and antioxidant potential of β‐sitosterol in streptozotocin‐induced experimental hyperglycemia. J. Diabetes 3, 29–37. 10.1111/j.1753-0407.2010.00107.x [DOI] [PubMed] [Google Scholar]
  28. Halliwell B. (1999). Antioxidant defenses. Free Radic. Biol. Med. 31, 4 261–272. 10.1080/10715769900300841 [DOI] [PubMed] [Google Scholar]
  29. Halliwell B., Whiteman M. (2004). Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?. Br. J. Pharmacol. 142, 231–255. 10.1038/sj.bjp.0705776 [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Hema R., Kumaravel S., Alagusundaram K. (2011). GC/MS determination of bioactive components of Murraya koenigii. J. Am. Sci. 7, 80–83. [Google Scholar]
  31. Ikeda I., Tanaka K., Sugano M., Vahouny G., Gallo L. (1988). Inhibition of cholesterol absorption in rats by plant sterols. J. Lipid Res. 29, 1573–1582. 10.1016/s0022-2275(20)38403-0 [DOI] [PubMed] [Google Scholar]
  32. Iwata K., Inayama T., Kato T. (1990). Effects of Spirulina platensis on plasma lipoprotein lipase activity in fructose-induced hyperlipidemic rats. J. Nutr. Sci. Vitaminol. 36, 165–171. 10.3177/jnsv.36.165 [DOI] [PubMed] [Google Scholar]
  33. Kadhim M. J., Al-Rubaye A. F., Hameed I. H. (2017). Determination of bioactive compounds of methanolic extract of vitis vinifera using GC-MS. Int. J. Toxicol. Pharmacol. Res. 9, 113–126. 10.25258/ijtpr.v9i02.9047 [DOI] [Google Scholar]
  34. Khan R. A., Khan M. R., Sahreen S., Shah N. A. (2012). Hepatoprotective activity of Sonchus asper against carbon tetrachloride-induced injuries in male rats: a randomized controlled trial. BMC Complement. Altern. Med. 12, 90. 10.1186/1472-6882-12-90 [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Khan R. A., Khan M. R., Shah N. A., Sahreen S., Siddiq P. (2015). Modulation of carbon tetrachloride-induced nephrotoxicity in rats by n-hexane extract of Sonchus asper . Toxicol. Ind. Health 31, 955–959. 10.1177/0748233713485885 [DOI] [PubMed] [Google Scholar]
  36. Kumar P. P., Kumaravel S., Lalitha C. (2010). Screening of antioxidant activity, total phenolics and GC-MS study of Vitex negundo. Afr. J. Biochem. Res. 4, 191–195. 10.5897/AJBR.9000213 [DOI] [Google Scholar]
  37. Lal S. S., Sukla Y., Singh A., Andriyas E. A., Lall A. M. (2009). Hyperuricemia, high serum urea and hypoproteinemia are the risk factor for diabetes. Asia J. Med. Sci. 1, 33–34. [Google Scholar]
  38. Li M., Kim D. H., Tsenovoy P. L., Peterson S. J., Rezzani R., Rodella L. F., et al. (2008). Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance. Diabetes 57, 1526–1535. 10.2337/db07-1764 [DOI] [PubMed] [Google Scholar]
  39. Luo C., Zhang W., Sheng C., Zheng C., Yao J., Miao Z. (2010). Chemical composition and antidiabetic activity of Opuntia Milpa Alta extracts. Chem. Biodivers. 7, 2869–2879. 10.1002/cbdv.201000077 [DOI] [PubMed] [Google Scholar]
  40. Mestry S. N., Dhodi J. B., Kumbhar S. B., Juvekar A. R. (2017). Attenuation of diabetic nephropathy in streptozotocin-induced diabetic rats by Punica granatum Linn. leaves extract. J. Traditional Complement. Med. 7, 273–280. 10.1016/j.jtcme.2016.06.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Munir M., Qureshi R. (2018). “Antidiabetic plants of Pakistan,” in Plant and human health Editors M. Ozturk and K. R. Hakeem (Springer; ), Vol. 1, 463–545. [Google Scholar]
  42. Omale J., Okafor P. N. (2008). Comparative antioxidant capacity, membrane stabilization, polyphenol composition and cytotoxicity of the leaf and stem of Cissus multistriata. Afr. J. Biotechnol. 7 (17), 29–33. 10.4314/ajb.v7i17.59240 [DOI] [Google Scholar]
  43. Omonije O. O., Saidu A. N., Muhammad H. L. (2019). Anti-diabetic activities of Chromolaena odorata methanol root extract and its attenuation effect on diabetic induced hepatorenal impairments in rats. Clin. Phytoscience 5, 23. 10.1186/s40816-019-0115-1 [DOI] [Google Scholar]
  44. Oyedapo O., Akinpelu B., Orefuwa S. (2004). Anti-inflammatory effect of Theobroma cacao, root extract. J. Trop. Med. Plants 5, 161–166. [Google Scholar]
  45. Panda S., Jafri M., Kar A., Meheta B. (2009). Thyroid inhibitory, antiperoxidative and hypoglycemic effects of stigmasterol isolated from Butea monosperma. Fitoterapia 80, 123–126. 10.1016/j.fitote.2008.12.002 [DOI] [PubMed] [Google Scholar]
  46. Parasuraman S., Balamurugan S., Christapher P. V., Petchi R. R., Yeng W. Y. (2015). Evaluation of antidiabetic and antihyperlipidemic effects of hydroalcoholic extract of leaves of Ocimum tenuiflorum (Lamiaceae) and prediction of biological activity of its metabolites. Phcog. Res. 7, 156. 10.4103/0974-8490.151457 [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Pari L., Latha M. (2002). Effect of Cassia auriculata flowers on blood sugar levels, serum and tissue lipids in streptozotocin diabetic rats. Singapore Med. J. 43, 617–621. [PubMed] [Google Scholar]
  48. Parker S., Moore P., Johnson L., Poitout V. (2003). Palmitate potentiation of glucose-induced insulin release: a study using 2-bromopalmitate. Metabolism 52, 1367–1371. 10.1016/s0026-0495(03)00279-8 [DOI] [PubMed] [Google Scholar]
  49. Patel D., Prasad S. K., Kumar R., Hemalatha S. (2012). An overview on antidiabetic medicinal plants having insulin mimetic property. Asian Pac. J. Trop. Biomed. 2, 320–330. 10.1016/S2221-1691(12)60032-X [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Peiris L. D., Dhanushka M., Jayathilake T. (2015). Evaluation of aqueous leaf extract of Cardiospermum halicacabum (L.) on fertility of male rats. Biomed. Res. Int. 2015, 175726. 10.1155/2015/175726 [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Preethi K. C., Kuttan R. (2009). Hepato and reno protective action of Calendula officinalis L. flower extract. Indian J. Exp. Biol. 47 (3), 163–168. [PubMed] [Google Scholar]
  52. Rajasekaran S., Sivagnanam K., Ravi K., Subramanian S. (2004). Hypoglycemic effect of Aloe vera gel on streptozotocin-induced diabetes in experimental rats. J. Med. Food 7, 61–66. 10.1089/109662004322984725 [DOI] [PubMed] [Google Scholar]
  53. Ramkumar K. M., Vanitha P., Uma C., Suganya N., Bhakkiyalakshmi E., Sujatha J. (2011). Antidiabetic activity of alcoholic stem extract of Gymnema montanum in streptozotocin-induced diabetic rats. Food Chem. Toxicol. 49, 3390–3394. 10.1016/j.fct.2011.09.027 [DOI] [PubMed] [Google Scholar]
  54. Reitman S., Frankel S. (1957). A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am. J. Clin. Pathol. 28, 56–63. 10.1093/ajcp/28.1.56 [DOI] [PubMed] [Google Scholar]
  55. Roeschlau P., Bernt P., Gruber W. (1974). Enzymatic determination of total cholesterol in serum. Clin. Chemis. 20 (6), 724–725. 10.1093/clinchem/20.6.724 [DOI] [PubMed] [Google Scholar]
  56. Sasaki M. (1966). A new ultramicro method for the determination of serum alkaline phosphatase. Use of Berthelot’s reaction for the estimation of phenol released by enzymatic activity. Igaku Seibutsugaku 70, 208–214. [PubMed] [Google Scholar]
  57. Sezik E., Aslan M., Yesilada E., Ito S. (2005). Hypoglycaemic activity of Gentiana olivieri and isolation of the active constituent through bioassay-directed fractionation techniques. Life Sci. 76, 1223–1238. 10.1016/j.lfs.2004.07.024 [DOI] [PubMed] [Google Scholar]
  58. Shah N. A., Khan M. R., Ahmad B., Noureen F., Rashid U., Ali Khan R. (2013). Investigation on flavonoid composition and anti free radical potential of Sida cordata. BMC Complement. Altern. Med. 13, 276. 10.1186/1472-6882-13-276 [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Sharma B., Salunke R., Balomajumder C., Daniel S., Roy P. (2010). Anti-diabetic potential of alkaloid rich fraction from Capparis decidua on diabetic mice. J. Ethnopharmacol. 127, 457–462. 10.1016/j.jep.2009.10.013 [DOI] [PubMed] [Google Scholar]
  60. Sharma U. K., Kumar R., Gupta A., Ganguly R., Singh A. K., Ojha A. K. (2019). Ameliorating efficacy of eugenol against metanil yellow induced toxicity in albino Wistar rats. Food Chem. Toxicol. 126, 34–40. 10.1016/j.fct.2019.01.032 [DOI] [PubMed] [Google Scholar]
  61. Shinde U., Phadke A., Nair A., Mungantiwar A., Dikshit V., Saraf M. N. (1999). Membrane stabilizing activity—a possible mechanism of action for the anti-inflammatory activity of Cedrus deodara wood oil. Fitoterapia 70, 251–257. 10.1016/s0367-326x(99)00030-1 [DOI] [Google Scholar]
  62. Shukla S., Mehta A., Mehta P., Bajpai V. (2011). Evaluation of comparative antidiabetic effects of ethanolic extracts of Caesalpinia bouncucella and Stevia rebaudiana in normal and alloxan-induced experimental rats. Rom. Biotechnol. Lett. 16, 6187–6199. [Google Scholar]
  63. Stanely P., Prince M., Menon V. P. (2000). Hypoglycaemic and other related actions of Tinospora cordifolia roots in alloxan-induced diabetic rats. J. Ethnopharmacol. 70, 9–15. 10.1016/s0378-8741(99)00136-1 [DOI] [PubMed] [Google Scholar]
  64. Su C. H., Hsu C. H., Ng L. T. (2013). Inhibitory potential of fatty acids on key enzymes related to type 2 diabetes. Biofactors 39, 415–421. 10.1002/biof.1082 [DOI] [PubMed] [Google Scholar]
  65. Swamy M. K., Sinniah U. R., Akhtar M. (2015). In vitro pharmacological activities and GC-MS analysis of different solvent extracts of Lantana camara leaves collected from tropical region of Malaysia. Evid. Based Complement. Alternat Med. 2015, 506413. 10.1155/2015/506413 [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Szkudelski T. (2001). The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol. Res. 50, 537–546. [PubMed] [Google Scholar]
  67. Tyagi T., Agarwal M. (2017). Phytochemical screening and GC-MS analysis of bioactive constituents in the ethanolic extract of Pistia stratiotes L. and Eichhornia crassipes (Mart.) solms. J. Pharmacogn. Phytochem. 6, 195–206. [Google Scholar]
  68. Tzeng T.-F., Liou S.-S., Chang C. J., Liu I.-M. (2014). The ethanol extract of Lonicera japonica (Japanese honeysuckle) attenuates diabetic nephropathy by inhibiting p-38 MAPK activity in streptozotocin-induced diabetic rats. Planta Med. 80, 121–129. 10.1055/s-0033-1360196 [DOI] [PubMed] [Google Scholar]
  69. Vadivel E., Gopalakrishnan S. (2011). GC-MS analysis of some bioactive constituents of Mussaenda frondosa Linn. Inter. J. Pharm. Bio Sci. 2, 313–320. [Google Scholar]
  70. van de Venter M., Roux S., Bungu L. C., Louw J., Crouch N. R., Grace O. M., et al. (2008). Antidiabetic screening and scoring of 11 plants traditionally used in South Africa. J. Ethnopharmacol. 119, 81–86. 10.1016/j.jep.2008.05.031 [DOI] [PubMed] [Google Scholar]
  71. Wu K. K., Huan Y. (2008). Streptozotocin-induced diabetic models in mice and rats. Curr. Protoc. Pharmacol. 5, 1–5. 10.1002/0471141755.ph0547s40 [DOI] [PubMed] [Google Scholar]
  72. Yehya A. H., Asif M., Kaur G., Hassan L. E., Al-Suede F. S., Majid A. M. A., et al. (2019). Toxicological studies of Orthosiphon stamineus (Misai Kucing) standardized ethanol extract in combination with gemcitabine in athymic nude mice model. J. Adv. Res. 15, 59–68. 10.1016/j.jare.2018.05.006 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author.

Articles from Frontiers in Pharmacology are provided here courtesy of Frontiers Media SA

RESOURCES